Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus …
S Zhang, X Sun, W Chang, Y Dai, X Ma - PloS one, 2015 - journals.plos.org
Background Vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous
VISA (hVISA) are associated with vancomycin treatment failure, and are becoming an …
VISA (hVISA) are associated with vancomycin treatment failure, and are becoming an …
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical …
Vancomycin-resistant Staphylococcus aureus (VRSA), Vancomycin-intermediate S. aureus
(VISA) and heterogeneous VISA (hVISA) are subject to vancomycin treatment failure. The …
(VISA) and heterogeneous VISA (hVISA) are subject to vancomycin treatment failure. The …
Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus …
RKC Fong, J Low, TH Koh, A Kurup - European journal of clinical …, 2009 - Springer
This retrospective case–control study was undertaken to review the clinical features
associated with heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) …
associated with heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) …
Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates
SJ van Hal, DL Paterson - Antimicrobial agents and …, 2011 - Am Soc Microbiol
The prevalence of heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA)
is 1.3% in published studies. Clinical associations include high-inoculum infections and …
is 1.3% in published studies. Clinical associations include high-inoculum infections and …
Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Isolates in Northeast China
J Hu, XX Ma, Y Tian, L Pang, LZ Cui, H Shang - PloS one, 2013 - journals.plos.org
Background Strains of Staphylococcus aureus with an intermediate level of resistance to
vancomycin (vancomycin-intermediate S. aureus, or VISA) or which contain subpopulations …
vancomycin (vancomycin-intermediate S. aureus, or VISA) or which contain subpopulations …
Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in …
Background The bactericidal activities of vancomycin and daptomycin were evaluated in a
large collection of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia strains …
large collection of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia strains …
Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features
O Denis, C Nonhoff, B Byl, C Knoop… - Journal of …, 2002 - academic.oup.com
In 1999, all clinical Staphylococcus aureus isolates from patients admitted to a Belgian
University hospital were tested for decreased vancomycin susceptibility. Three vancomycin …
University hospital were tested for decreased vancomycin susceptibility. Three vancomycin …
[HTML][HTML] Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical …
BACKGROUND: Hetero-resistant vancomycin intermediate Staphylococcus aureus (hVISA)
emerges worldwide in recent decade. The purpose of this study was to investigate the …
emerges worldwide in recent decade. The purpose of this study was to investigate the …
Prevalence and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates from 14 Cities in China
W Sun, H Chen, Y Liu, C Zhao… - Antimicrobial agents …, 2009 - Am Soc Microbiol
The prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)
among 1,012 vancomycin-susceptible methicillin (meticillin)-resistant S. aureus isolates …
among 1,012 vancomycin-susceptible methicillin (meticillin)-resistant S. aureus isolates …
Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus
C Hafer, Y Lin, J Kornblum, FD Lowy… - Antimicrobial agents …, 2012 - Am Soc Microbiol
Infections with vancomycin-intermediate Staphylococcus aureus (VISA) have been
associated with vancomycin treatment failures and poor clinical outcomes. Routine …
associated with vancomycin treatment failures and poor clinical outcomes. Routine …
相关搜索
- staphylococcus aureus meta analysis
- staphylococcus aureus clinical isolates
- staphylococcus aureus usa hospitals
- staphylococcus aureus vancomycin susceptibility
- staphylococcus aureus gene mutations
- meta analysis vancomycin resistance
- gene mutations clinical isolates
- staphylococcus aureus global prevalence
- vancomycin susceptibility clinical isolates
- staphylococcus aureus bloodstream infections
- staphylococcus aureus treatment outcomes
- staphylococcus aureus northeast china
- meta analysis global prevalence
- staphylococcus aureus vancomycin resistance
- staphylococcus aureus clinical features
- staphylococcus aureus belgian hospital